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CIDOFOVIR AND INTRAVENOUS IMMUNOGLOBULIN
FOR TREATMENT OF BK POLYOMAVIRUS NEPHROPATHY
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Abstract
BK polyomavirus nephropathy (BKN) is an important cause of
renal allograft dysfunction and loss. The mainstay of therapy is
reduced immunosuppression, but definitive protocols for the
diagnosis and management remain to be defined. We report here
a retrospective analysis of 6 patients with BKN treated with
cidofovir and intravenous immunoglobulin(IVIG). The patients
were followed for 6 months from the initiation of therapy. All
patients (3 cadaveric/3 live donors) underwent renal biopsy after
serum BK viral PCR (SBKPCR) was obtained in response to a
rise in creatinine concentration. The mean time from transplantation to diagnosis was 21.7 months (5, 14, 15, 24, 35, 35
months). One patient had positive SBKPCR without biopsy
evidence of BKN. In all patients immunosuppression was
reduced, and therapy with cidofovir (0.25-0.5mg/kg) and IVIG
(25 grams) was instituted weekly or bi-weekly. Mycophenolate
mofetil was discontinued, and the tacrolimus therapeutic trough
was decreased to 2-5 ng/mL in 5/6 patients. Therapy was
continued for 6 months or until SBKPCR was undetectable. The
mean nadir creatinine value after transplantation was 1.3mg/dL
(1,1.1, 1.1, 1.2, 1.3, 1.8). The mean creatinine value at time of
biopsy was 2.3 mg/dL (1.2, 1.4, 1.7, 2.8, 3, 3.6), and the mean

SBKPCR value at diagnosis was 870, 266 copies/mL (1.86, 23,
33, 38, 56, 370 x 104 copies/mL). The average number of
cidofovir doses was 8.3 (4, 6,6, 10, 12, 12 doses) with
concomitant IVIG. The mean SBKPCR at end of 6 months was
44,283 copies/dL (1.1, 1.8, 2.4, 5.4, 10, 245 x 103 copies/mL).
Five of 6 patients experienced a decrease in SBKPCR. The mean
creatinine value at the end of 6 months was 3.0 mg/dL (1.5, 2,
2.9, 3.3, 3.7, 4.4). After nine months from initiation of therapy,
the one patient with positive SBKPCR and biopsy negative for
BKN returned to a nadir creatinine (1.2 mg./dL) and
undetectable SBKPCR. Baseline renal function (the nadir
creatinine prior to the diagnosis of BK infection), was not
recovered in any patient at the end of six months. These data
suggest that the reduction of immunosuppression and addition of
cidofovir and intravenous immunoglobulin can arrest further
progression of BKN. Allograft dysfunction, however, was not
reversed and may reflect fibrosis secondary to the injury sustained
as a result of BKN. The one patient diagnosed by SBKPCR prior
to the development of BKN had the most favorable outcome.
Serologic screening prior to development of allograft dysfunction
may be warranted, but the timing and treatment strategies need
to be confirmed by larger studies.
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